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Experimental studies suggest that abnormal levels of calcium, magnesium, and phosphorus are 
implicated in pancreatic carcinogenesis. We investigated the associations between intakes of 
these minerals and the risk of pancreatic cancer in a case-control study conducted in 1994-1998. 
Cases of pancreatic cancer (n=150) were recruited from all hospitals in the metropolitan area of 
the Twin Cities and Mayo Clinic, Minnesota. Controls (n=459) were randomly selected from the 
general population and frequency matched to cases by age, sex, and race. All dietary variables 
were adjusted for energy intake using the residual method prior to data analysis. Logistic 
regression was performed to evaluate the associations between intake of three nutrients examined 
and the risk of pancreatic cancer. Total intake of calcium (936 vs. 1026 mg/day) and dietary 
intake of magnesium (315 vs. 331 mg/day) and phosphorus (1350 vs. 1402 mg/day) were 
significantly lower in cases than in controls. After adjustment for confounders, there were not 
significant associations of total and dietary intakes of calcium, magnesium, and phosphorus with 
the risk of pancreatic cancer. In addition, no significant interactions exist between intakes of 
these minerals and total fat on pancreatic cancer risk. In conclusion, the present study does not 
suggest that intakes of calcium, magnesium, and phosphorus were significantly associated with 
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Pancreatic cancer is the third leading cause of cancer-related death in the US 
(1)
. In 2019, 
approximately 56,770 subjects developed pancreatic cancer and an estimated 45,750 subjects 
died from the disease 
(1)
. Pancreatic cancer has been projected to become the second leading 
cause of cancer-related death by 2030 for the US population 
(2)
 despite improvements in five-
year cancer survival in the past decades 
(3)
. Early detection is an effective approach to reduce 
cancer mortality, but an accurate screening test is not yet available for pancreatic cancer.  The 
etiology of pancreatic cancer remains elusive as cigarette smoking, family history, chronic 
pancreatitis, and obesity are the only well-established risk factors 
(4)
. Therefore, it is important to 
identify modifiable risk factors for the primary prevention of pancreatic cancer. 
Calcium, magnesium, and phosphorus are essential minerals that are metabolically correlated 
and are crucial for many biologic and cellular functions 
(5)
, including bone turnover, energy 
metabolism, and inflammation 
(6-10)
. A growing body of evidence from experimental and human 
studies suggests that these minerals, particularly calcium, play a pivotal role in pancreatic 
carcinogenesis. Randomized trials showed that an increased intake of calcium significantly 
promoted fecal fat excretion and reduced levels of total cholesterol and low density lipoprotein 
(LDL)-cholesterol due to calcium soap formation and binding of bile acids in the intestine 
(6, 8)
. 
Animal studies revealed that high calcium diets induced weight loss through inhibiting 
lipogenesis, accelerating lipolysis, and enhancing thermogenesis 
(11)
. These findings offer a firm 
biological basis for the observation that dietary intake of calcium and the ratio of dietary calcium 
to phosphorus (Ca:P ratio) were inversely associated with obesity risk 
(12)
. Obesity and diabetes 
have been linked to an increased risk of pancreatic cancer in many epidemiological studies 
(13, 14)
.  
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related  to carcinogenesis.  Intracellular Ca
+2
 concentrations modulate the proliferation and 
apoptosis of immune cells and cancer cells, and the rise of cytosolic Ca
+2 
is necessary for 
efficient targeting and killing of tumor cells by cytotoxic T lymphocytes and natural killer cells 
(15)
. Magnesium deficiency is commonly found in patients with diabetes 
(7)
.  In a human 
experimental study, mild magnesium depletion significantly lowered serum levels of calcium and 
1,25-(OH)2D 
(7)
. Despite sound biological plausibility, the associations between intake of 
calcium, magnesium, and phosphorus and risk of pancreatic cancer have been inconsistent across 
previous epidemiological studies, with reports of a significant inverse association with intake of 
calcium 
(16)
 and magnesium 
(17)
, a significant positive association with calcium intake 
(18)
, and a 




, and phosphorus 
(21)
. 
Therefore, the present study sought to investigate these associations in a population-based, case-
control study in Minnesota. 
Materials and methods 
Study population  
The design and methodology of the case-control study of pancreatic cancer conducted from 
April 1994 to September 1998 in Minnesota have been described in detail elsewhere 
(22, 23)
. 
Briefly, cases were patients recently diagnosed with pancreatic ductal adenocarcinoma 
(International Classification of Disease for Oncology, 3rd ed., code C25) and were 20 years or 
older, English-speaking, and mentally competent. The source cohort was residents of the Upper 
Midwest and cases were recruited from all hospitals in the seven-county metropolitan area of 
Minneapolis and Saint Paul, Minnesota and the Mayo Clinic. Given the high fatality of 
pancreatic cancer, a rapid case-ascertainment system was adopted for case enrollment. The 
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the cases recruited to the study.  
Eligibility criteria for controls were the same as those for cases, disallowing a diagnosis of 
pancreatic cancer. Controls were randomly recruited from the source population of cases. 
Controls aged 20 to 64 years of age were identified from drivers’ licenses and state identity card 
database, while those aged 65 years or older were obtained from U.S. Health Care Financing 
Administration (now Centers for Medicare & Medicaid Services) records. Controls were 
frequency matched to cases by age (within 5 years), sex, and race.  
A total of 460 cases were identified and met the eligibility criteria. Of these, 202 were 
excluded due to death prior to being contacted or interviewed (n=85), refusal to participate 
(n=79), disallowance by their physician (n=31), and inability to be reached or contacted (n=7). 
After these exclusions, 258 participated in the study, yielding a response rate of 56.1%. A total of 
1141 eligible controls were ascertained and 676 of them agreed to participate in the study, giving 
a response rate of 59.2%. Dietary and alcohol intake data were not collected from 108 cases and 
217 controls largely because cases were too frail to endure the interview process or because 
controls declined to respond to the food frequency questionnaire.  Finally, data from 150 cases 
and 459 controls were available for the present analysis.    
Data collection 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and all procedures involving human subjects were approved by the institutional review 
boards of the University of Minnesota and the Mayo Clinic. Written informed consent was 
obtained from all subjects prior to the interview. A general questionnaire was used to solicit 
information regarding demographic characteristics (e.g. age, sex, and race), socioeconomic 
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slightly modified version of the Willett food frequency questionnaire (FFQ) was employed to 
assess the usual diet of the subjects. The Willett FFQ has been validated against dietary records, 
and validation studies showed that it had a reasonable level of reproducibility and validity for 
assessing individual nutrients and foods 
(24-26)
. Specifically, the average de-attenuated correlation 
coefficient between the energy-adjusted nutrient intakes measured by the FFQ and diet records 
among 127 men was 0.65, with de-attenuated correlation coefficients of 0.61, 0.71, and 0.63 for 
calcium, magnesium, and phosphorus, respectively 
(25)
. In the present study, we used a 131-item 
Willett FFQ (HarvardSSFQ.5/93) that had been modified for Minnesota Cancer Prevention 
Research Unit studies to include additional vegetables, fruits, and low-fat foods 
(26)
. These 
modifications might have somewhat changed the reproducibility and validity of the Willet FFQ. 
The FFQ used in this case-control study has 153 individual foods or food groups (including 
alcohol consumption) commonly consumed in the USA and questions on use of nutrient 
supplements. 
The general questionnaire and the FFQ were administered to study subjects by trained 
interviewers during face-to-face interviews. During the dietary survey, subjects were asked to 
recall how frequently they consumed each of the food items included in the FFQ in the year 
preceding pancreatic cancer diagnosis for cases or the referent date for controls. Dietary intake of 
total energy and nutrients were estimated by multiplying the portion size amount in each food 
item by the recalled frequency of consumption and summed over all food items. The amounts of 
energy and nutrients contained in portion sizes of all food items listed in the FFQ were derived 
from the Minnesota Colon Cancer Prevention Research Unit Studies database. Supplemental 
intake of calcium, magnesium, and phosphorus was also obtained from the responses of study 
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available for the present analysis. 
Statistical analysis 
All dietary variables were adjusted for energy intake using the residual method prior to data 
analysis 
(27)
. Differences in categorical and continuous variables were examined with chi-square 
test and t-test, respectively. Pancreatic cancer risk, in relation to total and dietary intake of 
calcium, magnesium, and phosphorus, was estimated by performing unconditional logistic 
regression. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by comparing 
the second, third, and fourth with the first quartile of total and dietary intakes of calcium, 
magnesium, and phosphorus. Cutoff points for creating the quartiles of each of the selected 
nutrients were based on their distributions among controls. Three regression models were 
constructed for each dietary variable. The first model estimated the effects of nutrients on 
pancreatic cancer risk without considering confounders. The second model was adjusted for age, 
sex, race, education (three levels), physical activity (hour/week), cigarette smoking (never, 
former and current), and alcohol consumption (serving/week). The third model was additionally 
adjusted for intake of total energy, total fat, fiber, fruits, and vegetables. The aforementioned 
covariates were adjusted as they are suspected or established confounders for the associations 
between dietary factors of interest and the risk of pancreatic cancer 
(4)
.  The statistical 
significance of the linear trend across quartiles of each of the nutrients examined was tested by 
assigning a median intake value to each quartile and then treating these as values of a continuous 
variable. 
As high calcium intake promotes fecal fat excretion and lowers levels of  total cholesterol 
and LDL-cholesterol 
(6, 8)
, the potential interactions on pancreatic cancer risk between each 
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were performed using SAS (version 9.4, SAS Institute Inc., Cary, NC), and a p-value of <0.05 
was considered statistically significant. 
Results 
The mean ages of cases and controls were 65.8 and 66.3 years, respectively. Approximately 
59.3% of cases and 56.9% of controls were male. Study subjects was predominately white 
(91.3% for cases and 98.0% for controls). Compared with controls, cases had a lower level of 
education and physical activity. Cases were more likely than controls to be former or current 
smokers and to report a history of diabetes (Table 1).  Total intake of calcium (936 vs. 1026 
mg/day) and dietary intake of magnesium (315 vs. 331 mg/day) and phosphorus (1350 vs. 1402 
mg/day) were significantly lower in cases than in controls (Table 2).  
After adjustment for confounders, total and dietary intakes of calcium, magnesium, and 
phosphorus were not statistically significantly associated with the risk of pancreatic cancer 
(Table 3). In addition, no significant associations were observed for the ratio of total intake of 
calcium to phosphorus or the ratio of dietary intakes of calcium to phosphorus (data not shown).  
There were no significant interactions of total and dietary intakes of calcium, magnesium, and 
phosphorus with total fat intake in relation to pancreatic cancer risk (all p-interaction values 
>0.05). The analyses stratified by the median of total fat intake (72.2 grams/day) did not reveal 
any clear patterns of differences in the associations between total and dietary intakes of nutrients 
considered and the risk of pancreatic cancer (Table A2 in the Appendix). 
Discussion  
The present study found no evidence that there were statistically significant associations 
between total and dietary intakes of calcium, magnesium, and phosphorus and the risk of 
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A number of cellular, animal, and human studies have suggested that low levels of calcium 
are involved in pancreatic carcinogenesis. Experimental studies have shown that intracellular 
Ca
+2
 concentrations play a crucial role in the regulation of proliferation and apoptosis of immune 
and tumor cells and in the elimination of tumor cells by the innate immune system 
(15)
. In 
addition, physiological intranuclear concentrations of calcium regulate DNA conformation and 
replication 
(28)
. Animal studies have consistently demonstrated the anti-obesity effect of dietary 
calcium. Transgenic mice fed on high-calcium diets exhibited an accelerated loss of fat and 
weight 
(11)
. The results of animal studies have been partially replicated in human intervention 
trials where high calcium intake promoted fecal fat excretion and favorably influenced insulin 
resistance biomarkers 
(6, 8)
. Although it is biologically plausible that calcium intake protects 
against pancreatic cancer, epidemiological studies evaluating the association between calcium 
intake and pancreatic cancer risk have yielded conflicting results. 
In 1990, Farrow et al. reported a reduced risk of pancreatic cancer associated with calcium 
intake in a small case-control study conducted in western Washington State 
(16)
. However, this 
potential beneficial effect was not replicated in a large case-control study performed in the San 
Francisco Bay area. In the latter study, dietary intake of calcium was associated with an elevated 
risk of pancreatic cancer among men [OR (95% CI) for ≥1200 mg/day vs. <500 mg/day: 2.8 (1.2, 
6.4)] 
(18)
. A pooled analysis of 14 prospective cohort studies in western countries showed inverse 
but nonsignificant associations of total and dietary intakes of calcium with the risk of pancreatic 
cancer [OR (95% CI) for dietary calcium intake of ≥1100 mg/day vs. <500 mg/day: 0.86 (0.69, 
1.07)] 
(19)
. Likewise, the present study found an inverse, but not statistically significant, 
association between total and dietary intakes of calcium and pancreatic cancer risk [OR (95% 
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with those with a median dietary intake of 541 mg/day].  
It is possible that the discrepant findings in the studies discussed above are due to differences 
in methods of case ascertainment, quality of calcium intake data, between-person variation in 
calcium intake, and control of confounding in those studies.  Of note, scarce data on the 
association between calcium intake and pancreatic cancer are available from Asian populations 
which have relatively low intake of calcium (e.g. the median intake of calcium was only 328 
mg/day for 11,937 Chinese adults residents) 
(29)
. Therefore, epidemiological analyses in Asian 
countries may help us better understand the association between a wide range of calcium intake 
and the occurrence of pancreatic cancer.  
Magnesium is involved in inflammatory cytokine excretion, immune response, DNA 
replication, and cell cycle regulation 
(30-33)
. Randomized trials have revealed that magnesium 
supplementation optimized circulating vitamin D levels 
(34)
. In addition, low intake of 
magnesium has been associated with an elevated risk of diabetes and metabolic syndrome, which 
are both risk factors for pancreatic cancer 
(35)
. Although the findings of these studies suggest that 
low magnesium intake may also play a role in pancreatic carcinogenesis, few epidemiological 
studies have investigated this hypothesis. In the Vitamins and Lifestyle Study (VITAL), subjects 
whose magnesium intake was <75% of the Recommended Dietary Allowances (RDA) (420 
mg/day for men and 320 mg/day for women) had a significantly increased risk of pancreatic 
cancer, compared with those who met the RDA for magnesium intake 
(17, 36)
. However, this 
potential protective effect of magnesium on pancreatic cancer was not found in the European 
Prospective Investigation into Cancer and Nutrition study (EPIC) 
(20)
 and the US male Health 
Professionals Follow-up Study (HPFS) 
(37)
. The present study showed inverse but nonsignificant 
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adjustment for confounders, which is largely consistent with findings from the EPIC and the 
HPFS.  
It has been reported that mice fed a diet high in phosphorus exhibited an increased number 
and size of carcinogen-induced lung epithelial tumors 
(38)
. The underlying mechanisms for this 
promoting effect could be that elevated intracellular phosphorus modulates active 
phosphorylated protein kinase B that stimulates cell cycle progression and other cellular events 
(38)
. Although cigarette smoking that emitted diverse carcinogens is a risk factor shared by lung 
cancer and pancreatic cancer 
(39)
, it remains unclear whether an increased risk of chemically-
induced lung tumor associated with high phosphorus intake in animals can be observed for 
pancreatic cancer in humans. To our knowledge, only one epidemiological study has investigated 
the association between phosphorus intake and pancreatic cancer risk 
(21)
. In that Italian 
population-based case-control study, phosphorus intake was not associated with an altered risk of 
pancreatic cancer 
(21)
, which is in agreement with the results of the present study.  
A major advantage of the present study is that a rapid case-ascertainment system was used to 
recruit all cases, which was necessary to maximize case enrollment due to the rapidly fatal nature 
of pancreatic cancer. As a result, all cases were interviewed in person and no proxy interviews, 
which are prone to recall bias, were used. To enhance the validity of dietary intake data collected 
from the FFQ, food models were provided to participants to help them estimate serving sizes for 
foods they consumed 
(40)
.  
There are some limitations in our study. The response rates were less than 60% for both cases 
and controls. Although the case response rate is relatively high among population-based case-
control studies of pancreatic cancer that do not rely on proxy interviews 
(41, 42)
, the 
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the study may be different from those who declined with regard to demographic, socioeconomic, 
and lifestyle factors. In addition, lack of complete dietary and alcohol intake data from some 
individuals who participated in the study reduced the number of cases and controls included in 
the present analysis and thus the power. Of note, however, our analysis showed that there were 
no significant differences in age, sex, race, education, smoking status, alcohol intake, and 
physical activity between all subjects considered in the present analysis and most subjects 
excluded from the analysis (69.4% of excluded cases and 56.7% of excluded controls) due to 
lack of data on dietary and alcohol intake.  A sample size of 150 cases and 459 controls may not 
offer adequate power for us to detect the potential moderate associations between intakes of 
minerals examined and risk of pancreatic cancer. Dietary measurement error, arising from 
intentional or unintentional misreporting of individual food intake, might have led to 
misclassification of some subjects with regard to intake of the nutrients examined and 
consequently attenuated the risk estimates if such measurement error were non-differential and 
substantial.  
Reverse causality should be considered in any case-control studies of diet and cancer as 
patients may change their dietary habits in response to clinical symptoms and medical treatments 
after diagnosis.  Although we assessed diet history for the period prior to diagnosis to avoid this 
bias, the illness may affect recall as well. Overweight and obesity have been linked to pancreatic 
cancer 
(43)
, but we were unable to adjust for body mass index in our analysis because body height 
and weight were not measured due to an oversight. This limitation was in part overcome by 
adjustment for energy intake and physical activity, the two main determinants of body mass 
index 
(40)
. Overweight and obesity are associated with an increased risk of diabetes 
(44)
. In a 
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patients with diabetes diagnosed within two years of cancer diagnosis to minimize the possibility 
of diabetes induced by subclinical pancreatic tumor. This sensitivity analysis revealed that an 
additional adjustment for diabetes did not materially alter our original results. Nevertheless, 
failure to adjust for body mass index might have distorted our findings. This case-control study 
was conducted 22-24 years ago. As there is still no screening test available for pancreatic cancer, 
most cases continue to be diagnosed at late stages.  Survival from pancreatic cancer has 
improved slightly over the period since this study was conducted primarily due to improved 
treatment. For example, 1-year relative survival was 18.5% for 1990-1994 and 37.3% in 2016 
(45)
. Since our study was focused on etiology and the cases in our study were recruited very soon 
after diagnosis, the trends in survival are unlikely to have affected the relevance of our findings. 
In conclusion, there were not significant associations between total and dietary intakes of 
calcium, magnesium, and phosphorus, and the risk of pancreatic cancer in this Upper 
Midwestern population of the U.S. More epidemiological studies are warranted to evaluate 
whether calcium, magnesium, and phosphorus confer an altered risk of pancreatic cancer in 
populations with a relatively low intake of these minerals (e.g. Eastern Asian populations). As 
dietary intake of energy and nutrients are subject to the measurement error derived from recall 
bias, urinary biomarkers of calcium, magnesium, and phosphorus should be considered in future 
studies 
(46)
. A clear understanding of the roles of these nutrients in pancreatic cancer etiology 









bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







Financial support Research reported in this publication was supported by the National Institutes 
of Health (K.E.A., grant number R01CA58697). The content is solely the responsibility of the 
authors and does not necessarily represent the official views of the National Institutes of Health. 
The National Institutes of Health had no role in the design, analysis or writing of this article. 
Conflict of interest The authors declare that they have no conflict of interest. 
Ethics approval This study has been approved by the institutional review boards of the 
University of Minnesota and the Mayo Clinic and has therefore been performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments. All study subjects provided written informed consents prior to their inclusion in the 
study.  
Authors’ Contributions K. E. A. and J. Z. designed research; H. F., Y. Y., K. E. A., and J. Z. 
conducted research;  H. F., Y. Y., and J. Z. performed statistical analysis; all authors drafted 
and/or revised it critically for important intellectual content; J.Z. is responsible for final content 









bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term








1. American Cancer Society (2019) Cancer facts and figures. Atlanda, GA: American 
Cancer Society. 
2. Rahib L, Smith BD, Aizenberg R et al. (2014) Projecting cancer incidence and deaths to 
2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. 
Cancer Res 74, 2913-2921. 
3. Lepage C, Capocaccia R, Hackl M et al. (2015) Survival in patients with primary liver 
cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 
1999-2007: Results of EUROCARE-5. Eur J Cancer 51:2169-2178. 
4. Yadav D & Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic 
cancer. Gastroenterology 144, 1252-1261. 
5. Blaine J, Chonchol M Levi M (2015) Renal control of calcium, phosphate, and 
magnesium homeostasis. Clin J Am So Nephrol 10, 1257-1272. 
6. Bendsen NT, Hother AL, Jensen SK et al. (2008) Effect of dairy calcium on fecal fat 
excretion: a randomized crossover trial. Int J Obes (Lond) 32, 1816-1824. 
7. Fatemi S, Ryzen E, Flores J et al. (1991) Effect of experimental human magnesium 
depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J 
Clin Endocrinol Metab 73, 1067-1072. 
8. Soerensen KV, Thorning TK, Astrup A et al. (2014) Effect of dairy calcium from cheese 
and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr 
99, 984-991. 
9. Zemel MB (2003) Mechanisms of dairy modulation of adiposity. J Nutr 133, 252S-256S. 








bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







obesity risk. Nutr Rev 62, 125-131. 
11. Zemel M & Ph.D S (2008) Dietary Calcium and Dairy Modulation of Adiposity and 
Obesity Risk. Nutr Rev 62, 125-131. 
12. Pereira Dde C, Lima RP, de Lima RT et al. (2013) Association between obesity and 
calcium:phosphorus ratio in the habitual diets of adults in a city of Northeastern Brazil: 
an epidemiological study. Nutr J 12, 90. doi: 10.1186/1475-2891-12-90 
13. Berrington de Gonzalez A, Sweetland S Spencer E (2003) A meta-analysis of obesity and 
the risk of pancreatic cancer. Br J Cancer 89, 519-523. 
14. Elena JW, Steplowski E, Yu K et al. (2013) Diabetes and risk of pancreatic cancer: a 
pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 
24:13-25. 
15. Schwarz EC, Qu B Hoth M (2013) Calcium, cancer and killing: the role of calcium in 
killing cancer cells by cytotoxic T lymphocytes and natural killer cells. Biochim Biophys 
Acta Mol Cell Res 1833, 1603-1611. 
16. Farrow DC & Davis S (1990) Diet and the risk of pancreatic cancer in men. Am J 
Epidemiol 132, 423-431. 
17. Dibaba D, Xun P, Yokota K et al. (2015) Magnesium intake and incidence of pancreatic 
cancer: the VITamins and Lifestyle study. Br J Cancer 113:1615-21. 
18. Zablotska LB, Gong Z, Wang F et al. (2011) Vitamin D, calcium, and retinol intake, and 
pancreatic cancer in a population-based case-control study in the San Francisco Bay area. 
Cancer Causes Control 22, 91-100. 
19. Genkinger JM, Wang M, Li R et al. (2014) Dairy products and pancreatic cancer risk: a 








bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







20. Molina‐Montes E, Wark PA, Sánchez MJ et al. (2012) Dietary intake of iron, heme‐
iron and magnesium and pancreatic cancer risk in the European prospective investigation 
into cancer and nutrition cohort. Int J Cancer 131, E1134-E1147. 
21. Bravi F, Polesel J, Bosetti C et al. (2011) Dietary intake of selected micronutrients and 
the risk of pancreatic cancer: an Italian case-control study. Ann Oncol 22, 202-206. 
22. Anderson KE, Sinha R, Kulldorff M et al. (2002) Meat intake and cooking techniques: 
associations with pancreatic cancer. Mutation Research/Fundamental and Molecular 
Mechanisms of Mutagenesis 506, 225-231. 
23. Gross M, Kruisselbrink T, Anderson K et al. (1999) Distribution and concordance of N-
acetyltransferase genotype and phenotype in an American population. Cancer 
Epidemiology and Prevention Biomarkers 8, 683-692. 
24. Feskanich D, Rimm EB, Giovannucci EL et al. (1993) Reproducibility and validity of 
food intake measurements from a semiquantitative food frequency questionnaire. J Am 
Diet Assoc 93, 790-796. 
25. Rimm EB, Giovannucci EL, Stampfer MJ et al. (1992) Reproducibility and validity of an 
expanded self-administered semiquantitative food frequency questionnaire among male 
health professionals. Am J Epidemiol 135, 1114-1126. 
26. Smith-Warner SA, Elmer PJ, Fosdick L et al. (1997) Reliability and comparability of 
three dietary assessment methods for estimating fruit and vegetable intakes. 
Epidemiology 8, 196-201. 
27. Willett W & Stampfer MJJAjoe (1986) Total energy intake: implications for 
epidemiologic analyses. Am J Epidemiol 124:17-27. 








bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







at the dinucleotide repeat (TG/AC)n. Proc Natl Acad Sci U S A 95, 5981-5986. 
29. Huang F, Wang Z, Zhang J et al. (2018) Dietary calcium intake and food sources among 
Chinese adults in CNTCS. PLoS One 13, e0205045. 
30. Dai Q, Sandler R, Barry E et al. (2012) Calcium, magnesium, and colorectal cancer. 
Epidemiology 23, 504-505. 
31. Tao MH, Dai Q, Millen AE et al. (2016) Associations of intakes of magnesium and 
calcium and survival among women with breast cancer: results from Western New York 
Exposures and Breast Cancer (WEB) Study. Am J Cancer Res 6, 105-113. 
32. Tam M, Gomez S, Gonzalez-Gross M et al. (2003) Possible roles of magnesium on the 
immune system. Eur J Clin Nutr 57, 1193-1197. 
33. Vernon WB (1988) The role of magnesium in nucleic-acid and protein metabolism. 
Magnesium 7, 234-248. 
34. Dai Q, Zhu X, Manson JE et al. (2018) Magnesium status and supplementation influence 
vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr 108, 
1249-1258. 
35. Long S & Romani AM (2014) Role of Cellular Magnesium in Human Diseases. Austin J 
Nutr Food Sci 2:1051. 
36. NASEM (2017) Dietary Reference Intakes Tables and Application. 
http://nationalacademies.org/HMD/Activities/Nutrition/SummaryDRIs/DRI-Tables.aspx 
(accessed June 2017). 
37. Kesavan Y, Giovannucci E, Fuchs CS et al. (2009) A prospective study of magnesium 
and iron intake and pancreatic cancer in men. Am J Epidemiol 171, 233-241. 








bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







hypertension. Ann N Y Acad Sci 1301, 1-8. 
39. Meyer J, Rohrmann S, Bopp M et al. (2015) Impact of smoking and excess body weight 
on overall and site-specific cancer mortality risk. Cancer Epidemiol Biomarkers Prev 24, 
1516-1522. 
40. Marley AR, Fan H, Hoyt ML et al. (2018) Intake of methyl-related nutrients and risk of 
pancreatic cancer in a population-based case-control study in Minnesota. Eur J Clin Nutr 
72, 1128-1135. 
41. Baghurst PA, McMichael AJ, Slavotinek AH et al. (1991) A case-control study of diet 
and cancer of the pancreas. Am J Epidemiol 134, 167-179. 
42. Nkondjock A, Krewski D, Johnson KC et al. (2005) Dietary patterns and risk of 
pancreatic cancer. Int J Cancer 114, 817-823. 
43. Larsson SC, Orsini N Wolk A (2007) Body mass index and pancreatic cancer risk: A 
meta-analysis of prospective studies. Int J Cancer 120, 1993-1998. 
44. DeFronzo RA, Ferrannini E, Groop L et al. (2015) Type 2 diabetes mellitus. Nat Rev Dis 
Primers 1, 1-22. 
45. Howlader N, Noone A, Krapcho Me et al. (2020) SEER Cancer Statistics Review, 1975-
2017. 606. 
46. Sun Q, Bertrand KA, Franke AA et al. (2017) Reproducibility of urinary biomarkers in 









bridge.org/core . IP address: 72.105.175.25 , on 05 Feb 2021 at 21:54:04 , subject to the Cam
bridge Core term







Table 1.  Characteristics of cases and controls in a population-based, case-control study of pancreatic 










Age (year) 65.8 (10.9) 66.3 (12.1) 0.64 
Sex   0.48 
  Male 89 (59.3%) 261 (56.9%)  
  Female                                                                    59 (39.3%) 198 (43.1%)   
  Missing 2 (1.3%) N/A  
Race   <0.001 
  White 137 (91.3%) 450 (98.0%)  
  Black 7 (4.7%) 3 (0.7%)  
  Other 6 (4%) 6 (1.3%)   
Education   <0.001 
  High school graduate 56 (37.3%) 116 (25.3%)  
  Some college or more  76 (50.7%) 319 (69.5%)  
  Some high school or less 18 (12.0%) 24 (5.2%)   
Cigarette smoking   0.12 
  Former smoker 63 (42.0%) 196 (42.7%)  
  Never smoker 57 (38.0%) 215 (46.8%)  
  Current smoker 23 (15.3%) 48 (10.5%)   
  Missing 7 (4.7%) N/A  
Alcohol intake (Serving/week)  3.4 (6.9) 4.6 (8.5) 0.065 
Diabetes mellitus     <0.001 
  Yes 31 (20.7%) 33 (7.2%)  
  No 101 (67.3%) 426 (92.8%)  
  Missing 18 (12.0%) N/A  
Physical activity (h/week)
c
    
  Light 23.0 (17.0) 27.1 (16.2) 0.013 
  Moderate 15.2 (13.1) 18.1 (12.7) 0.022 
  Heavy 5.1 (11.8) 3.9 (5.5) 0.27 
a 
Some variables have missing data. 
b
 Values shown are mean (SD) for continuous variables and number (%) for categorical variables. T-test 
and Chi-square test were used to compare differences in continuous and categorical variables between 
cases and controls, respectively. 
c
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Table 2.  Difference in intake of calcium, magnesium, and phosphorus (mean and SD) between cases and 










Calcium (mg/day)    
Total Calcium 936 (448) 1026 (448) 0.033 
Dietary Calcium 835 (390) 883 (344) 0.17 
Magnesium (mg/day)    
Total Magnesium 333 (89) 348 (85) 0.077 
   Dietary Magnesium 315 (75) 331 (75) 0.026 
Phosphorus (mg/day)    
Total Phosphorus 1368 (281) 1417 (274) 0.062 
Dietary Phosphorus 1350 (262) 1402 (271) 0.040 
a 
Some variables have missing data. 
b
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p- trend First Second Third  Fourth 
Total Calcium      
  Median (mg/day) 575 789 1148 1532  
  Cases/Controls 43/114 49/115 30/115 28/115  
  Crude OR (95% CI) 1.00 1.13 (0.70, 1.83) 0.70 (0.41, 1.18) 0.65 (0.38, 1.11) 0.030 
  Adjusted OR1 (95% CI)
a
 1.00 1.01 (0.58, 1.73) 0.60 (0.33, 1.11) 0.70 (0.38, 1.29) 0.10 
  Adjusted OR2 (95% CI)
b
 1.00 1.01 (0.58, 1.77) 0.60 (0.32, 1.12) 0.69 (0.37, 1.28) 0.10 
Dietary Calcium      
  Median (mg/day) 541 716 941 1300  
  Cases/Controls 40/114 57/116 26/115 27/114  
  Crude OR (95% CI) 1.00 1.40 (0.87, 2.26) 0.64 (0.37, 1.12) 0.67 (0.39, 1.17) 0.022 
  Adjusted OR1 (95% CI)
a
 1.00 1.42 (0.83, 2.44) 0.70 (0.37, 1.31) 0.75 (0.40, 1.40) 0.087 
  Adjusted OR2 (95% CI)
b
 1.00 1.45 (0.82, 2.57) 0.70 (0.37, 1.34) 0.72 (0.38, 1.37) 0.074 
Total Magnesium      
  Median (mg/day) 264 316 364 434  
  Cases/Controls 56/114 28/116 35/114 31/115  
  Crude OR (95% CI) 1.00 0.49 (0.29, 0.83) 0.62 (0.38, 1.02) 0.55 (0.33, 0.91) 0.038 
  Adjusted OR1 (95% CI)
a
 1.00 0.58 (0.33, 1.04) 0.69 (0.40, 1.20) 0.59 (0.32, 1.07) 0.10 
  Adjusted OR2 (95% CI)
b
 1.00 0.58 (0.31, 1.06) 0.68 (0.38, 1.23) 0.59 (0.30, 1.16) 0.17 
Dietary Magnesium
 
      
  Median (mg/day) 256 311 344 399  
  Cases/Controls 54/114 33/115 35/115 28/115  
  Crude OR (95% CI) 1.00 0.61 (0.37, 1.00) 0.64 (0.39, 1.06) 0.51 (0.30, 0.87) 0.013 
  Adjusted OR1 (95% CI)
a
 1.00 0.60 (0.34, 1.07) 0.75 (0.43, 1.32) 0.65 (0.36, 1.17) 0.16 
  Adjusted OR2 (95% CI)
b
 1.00 0.60 (0.33, 1.11) 0.73 (0.40, 1.34) 0.73 (0.36, 1.50) 0.38 
Total Phosphorus       
  Median (mg/day) 1124 1298 1475 1759  
  Cases/Controls 50/115 32/114 41/116 27/114  
  Crude OR (95% CI) 1.00 0.65 (0.39, 1.08) 0.81 (0.50, 1.32) 0.54 (0.32, 0.93) 0.055 
  Adjusted OR1 (95% CI)
a
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  Adjusted OR2 (95% CI)
b
 1.00 0.60 (0.33, 1.10) 0.93 (0.52, 1.63) 0.63 (0.34, 1.16) 0.29 
Dietary Phosphorus       
  Median (mg/day) 1116 1293 1452 1731  
  Cases/Controls 48/114 36/115 43/115 23/115  
  Crude OR (95% CI) 1.00 0.74 (0.45, 1.23) 0.89 (0.55, 1.44) 0.47 (0.27, 0.83) 0.019 
  Adjusted OR1 (95% CI)
a
 1.00 0.73 (0.41, 1.31) 0.92 (0.52, 1.61) 0.57 (0.31, 1.05) 0.12 
  Adjusted OR2 (95% CI)
b
 1.00 0.80 (0.44, 1.43) 1.02 (0.57, 1.80) 0.61 (0.32, 1.15) 0.19 
Abbreviations: OR, odds ratio; CI, confidence interval 
a
 Adjusted for age, sex, race, education, physical activity, cigarette smoking, and alcohol consumption per week 
b
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Table A1.  Characteristics of subjects in a population-based, case-control study of pancreatic cancer in Minnesota, stratified by quartiles of total calcium intake, total magnesium intake, and total 
phosphorus intake, 1994–1998a 
 Quartile of total calcium intake Quartile of total magnesium intake Quartile of total phosphorus intake 
 First Second Third Fourth   First Second Third Fourth   First Second Third Fourth 
 
 
            
575 789 1148 1532 264 316 364 434 1124 1298 1475 1759 
Age (year) 64.3 (12.3) 66.5 (11.5) 66.1 (12.7) 68.1 (10.4) 65.0 (13.0) 66.7 (12.2) 64.4 (11.2) 66.0 (10.5) 64.0 (12.6) 66.8 (11.3) 67.6 (11.5) 66.6 (11.4) 
Sex             
  Male 112 (71.3) 108 (65.9) 73 (50.3) 57 (40.0) 109 (64.1) 91 (63.2) 87 (58.4) 63 (43.1) 107 (64.9) 86 (58.9) 86 (54.8) 71 (50.3) 
  Female                                                                    44 (28.1) 55 (33.5) 72 (49.7) 86 (60.1) 59 (34.7) 53 (36.8) 62 (41.6) 83 (56.9) 57 (34.5) 59 (40.4) 71 (45.2) 70 (49.7) 
  Missing 1 (0.6) 1 (0.6) 0 (0) 0 (0) 2 (1.2) 0(0) 0(0) 0(0) 1 (0.6) 1 (0.7) 0 (0) 0 (0) 
Race             
  White 150 (95.5) 158 (96.3) 139 (95.9) 140 (97.9) 161 (94.7) 142 (98.6) 144 (96.6) 140 (95.9) 161 (97.6) 141 (96.6) 149 (94.9) 136 (96.6) 
  Black 5 (3.2) 1 (0.6) 1 (0.7) 3 (2.1) 4 (2.4) 2 (1.4) 2 (1.4) 2 (1.4) 2 (1.2) 1 (0.7) 4 (2.5) 2 (1.4) 
  Other 2 (1.3) 5 (3.1) 5 (3.4) 0 (0) 5 (2.9) 0 (0) 3 (2.0) 4 (2.7) 2 (1.2) 4 (2.7) 4 (2.6) 2 (1.4) 
Education             
  High school graduate 47 (29.9) 51 (31.1) 30 (20.7) 44 (30.8) 66 (38.8) 37 (25.7) 37 (24.9) 32 (21.9) 54 (32.7) 46 (31.5) 36 (22.9) 36 (255) 
  Some college or more  93 (59.3) 100 (61.0) 105 (72.4) 97 (67.8) 88 (51.8) 94 (65.3) 103 (69.1) 110 (75.4) 96 (58.2) 88 (60.3) 112 (71.3) 99 (70.2) 
  Some high school or less 17 (10.8) 13 (7.9) 10 (6.9) 2 (1.4) 16 (9.4) 13 (9.0) 9 (6.0) 4 (2.7) 15 (9.1) 12 (8.2) 9 (5.7) 6 (4.3) 
Cigarette smoking             
  Former smoker 71 (45.3) 77 (47.0) 53 (36.6) 58 (40.6) 69 (40.6) 62 (43.1) 66(44.3) 62 (42.5) 76 (46.0) 63 (43.2) 55 (35.0) 65 (46.1) 
  Never smoker 58 (36.9) 69 (12.0) 74 (51.0) 71 (49.7) 70 (41.1) 66 (45.8) 65 (43.6) 71 (48.6) 60 (36.4) 65 (44.5) 85 (54.1) 62 (44.0) 
  Current smoker 28 (17.8) 15 (9.2) 16 (11.0) 12 (8.3) 30 (17.7) 16 (11.1) 17 (11.4) 8 (5.5) 28 (17.0) 17 (11.6) 15 (9.6) 11 (7.8) 
  Missing 0 (0) 3 (1.8) 2 (1.4) 2 (1.4) 1 (0.6) 0 (0) 1 (0.7) 5 (3.4) 1 (0.6) 1 (0.7) 2 (1.3) 3 (2.1) 
Alcohol intake (serving/week) 6.9 (11.9) 4.0 (6.8) 3.5 (6.2) 2.8 (5.3) 4.3 (7.9) 5.3 (10.0) 4.5 (8.5) 3.3 (5.7) 7.9 (12.4) 3.7 (6.3) 3.0 (5.1) 2.4 (4.3) 
Diabetes mellitus             
  Yes 8 (5.1) 21 (12.8) 20 (13.8) 15 (10.5) 12 (7.1) 13 (9.0) 18 (12.1) 21 (14.4) 9 (5.5) 12 (8.2) 25 (15.9) 18 (12.8) 
  No 145 (92.4) 138 (84.2) 119 (82.1) 125 (87.4) 155 (91.2) 126 (87.5) 127 (85.2) 119 (81.5) 148 (89.6) 129 (88.4) 129 (82.2) 121 (85.8) 
  Missing 4 (2.5) 5 (3.0) 6 (4.1) 3 (2.1) 3 (1.7) 5 (3.5) 4 (2.7) 6 (4.1) 8 (4.9) 5 (3.4) 3 (1.9) 2 (1.4) 
Physical activity (hour/week)b             
  Light 27.2 (17.1) 25.3 (15.6) 26.6 (15.8) 25.8 (17.2) 25.0 (16.4) 27.7 (16.9) 26.5 (17.4) 26.2 (15.9) 26.6 (15.9) 27.3 (16.7) 25.3 (16.1) 25.8 (28.2) 
  Moderate 18.4 (14.1) 17.2 (12.0) 17.3 (12.6) 17.0 (12.6) 15.1 (11.7) 19.3 (12.8) 16.7 (12.9) 19.4 (13.7) 16.7 (12.5) 18.6 (13.1) 17.5 (13.9) 17.3 (11.8) 
  Heavy 4.6 (6.1) 4.2 (6.8) 4.4 (10.3) 3.4 (5.2) 4.3 (7.5) 4.7 (6.9) 3.2 (4.6) 4.4 (9.5) 4.4 (7.0) 3.9 (5.8) 4.8 (10.5) 3.3 (4.3) 
a Some variables have missing data. 
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lower total fat intake (<72.2 g/day) 
p- trend 
Higher total fat intake (≥72.2 g/day) 
p- trend 
Quartile Quartile 
First Second Third Fourth First Second Third Fourth 
Total Calcium           
  Median (mg/day) 582 847 1211 1569  571 746 1029 1473  
  Cases/Controls 24/60 19/59 14/59 10/59  21/56 24/55 21/56 17/55  
  Crude OR (95% CI) 1.00 0.81 (0.40, 1.62) 0.59 (0.28, 1.26) 0.42 (0.19, 0.96) 0.027 1.00 1.16 (0.58, 2.33) 1.00 (0.49, 2.03) 0.82 (0.39, 1.73) 0.47 
  Adjusted OR1 (95% CI)a 1.00 1.09 (0.48, 2.48) 0.78 (0.32, 1.91) 0.53 (0.20, 1.38) 0.13 1.00 1.02 (0.48, 2.16) 0.86 (0.40, 1.88) 0.74 (0.33, 1.67) 0.41 
  Adjusted OR2 (95% CI)b 1.00 1.20 (0.50, 2.88) 0.79 (0.31, 1.99) 0.56 (0.21, 1.50) 0.17 1.00 0.94 (0.42, 2.06) 0.79 (0.35, 1.78) 0.71 (0.31, 1.63) 0.38 
Dietary Calcium           
  Median (mg/day) 551 767 1060 1319  538 695 862 1253  
  Cases/Controls 19/59 23/59 10/60 15/59  22/55 27/56 18/56 16/55  
  Crude OR (95% CI) 1.00 1.21 (0.60, 2.45) 0.52 (0.22, 1.21) 0.79 (0.37, 1.70) 0.20 1.00 1.20 (0.61, 2.37) 0.80 (0.39, 1.66) 0.73 (0.35, 1.53) 0.24 
  Adjusted OR1 (95% CI)a 1.00 1.52 (0.66, 3.53) 0.74 (0.28, 1.94) 1.02 (0.40, 2.57) 0.57 1.00 1.06 (0.50, 2.23) 0.77 (0.34, 1.72) 0.70 (0.31, 1.59) 0.30 
  Adjusted OR2 (95% CI)b 1.00 1.69 (0.67, 4.22) 0.73 (0.27, 2.00)  1.08 (0.41, 2.81) 0.59 1.00 0.87 (0.39, 1.95) 0.68 (0.29, 1.59) 0.63 (0.27, 1.47) 0.26 
Total Magnesium           
  Median (mg/day) 284 335 384 452  247 304 336 407  
  Cases/Controls 24/59 19/59 13/59 11/60  29/56 16/55 15/55 23/56  
  Crude OR (95% CI) 1.00 0.79 (0.39, 1.60) 0.54 (0.25, 1.16) 0.45 (0.20, 1.00) 0.031 1.00 0.56 (0.27, 1.15) 0.53 (0.25, 1.09) 0.79 (0.41, 1.54) 0.51 
  Adjusted OR1 (95% CI)a 1.00 0.92 (0.41, 2.09) 0.69 (0.29, 1.63) 0.54 (0.21, 1.38) 0.16 1.00 0.68 (0.31, 1.09) 0.48 (0.21, 1.09) 0.87 (0.40, 1.87) 0.65 
  Adjusted OR2 (95% CI)b 1.00 1.02 (0.43, 2.39) 0.85 (0.33, 2.15) 0.68 (0.23, 2.00) 0.45 1.00 0.53 (0.23, 1.23) 0.36 (0.14, 0.88) 0.70 (0.30, 1.66) 0.45 
Dietary Magnesium            
  Median (mg/day) 279 327 365 415  240 297 325 373  
  Cases/Controls 22/59 13/59 18/59 14/59  27/56 22/55 16/56 18/55  
  Crude OR (95% CI) 1.00 0.59 (0.27, 1.28) 0.82 (0.40, 1.68) 0.63 (0.29, 1.34) 0.32 1.00 0.83 (0.42, 1.63) 0.59 (0.29, 1.22) 0.68 (0.34, 1.37) 0.19 
  Adjusted OR1 (95% CI)a 1.00 0.86 (0.35, 2.11) 1.29 (0.56, 2.95) 0.85 (0.34, 2.10) 0.94 1.00 0.94 (0.44, 1.99) 0.71 (0.32, 1.56) 0.78 (0.34, 1.78) 0.45 
  Adjusted OR2 (95% CI)b 1.00 0.90 (0.35, 2.29) 1.77 (0.72, 4.37) 1.23 (0.43, 3.49) 0.44 1.00 0.74 (0.32, 1.71) 0.54 (0.22, 1.31) 0.61 (0.23, 1.62) 0.24 
Total Phosphorus            
  Median (mg/day) 1135 1344 1536 1773  1117 1274 1431 1709  
  Cases/Controls 23/60 18/59 16/59 10/59  25/56 18/55 20/56 20/55  
  Crude OR (95% CI) 1.00 0.80 (0.39, 1.62) 0.71 (0.34, 1.47) 0.44 (0.19, 1.01) 0.052 1.00 0.73 (0.36, 1.49) 0.80 (0.40, 1.60)  0.81 (0.41, 1.63) 0.66 
  Adjusted OR1 (95% CI)a 1.00 0.83 (0.35, 1.99) 1.13 (0.47, 2.72) 0.56 (0.21, 1.49) 0.36 1.00 0.68 (0.31, 1.49) 0.88 (0.40, 1.92) 0.81 (0.37, 1.77) 0.75 
  Adjusted OR2 (95% CI)b 1.00 1.02 (0.40, 2.58) 1.28 (0.52, 3.16) 0.66 (0.24, 1.82) 0.55 1.00 0.64 (0.29, 1.43) 0.86 (0.38, 1.93) 0.82 (0.37, 1.83) 0.82 
Dietary Phosphorus            
  Median (mg/day) 1125 1332 1514 1753  1101 1267 1417 1657  
  Cases/Controls 23/59 18/59 15/60 11/59  24/55 19/56 23/55 17/56  
  Crude OR (95% CI) 1.00 0.78 (0.38, 1.60) 0.64 (0.31, 1.35) 0.48 (0.21, 1.07) 0.059 1.00 0.78 (0.38, 1.58) 0.96 (0.48, 1.90) 0.70 (0.34, 1.43) 0.42 
  Adjusted OR1 (95% CI)a 1.00 0.75 (0.31, 1.79) 1.03 (0.42, 2.51) 0.59 (0.23, 1.53) 0.39 1.00 0.70 (0.32, 1.52) 1.02 (0.48, 2.19) 0.69 (0.31, 1.54) 0.52 
  Adjusted OR2 (95% CI)b 1.00 0.96 (0.38, 2.43) 1.15 (0.46, 2.86) 0.73 (0.27, 1.98) 0.63 1.00 0.62 (0.28, 1.41) 1.01 (0.46, 2.23) 0.70 (0.31, 1.58) 0.59 
Abbreviations: OR, odds ratio; CI, confidence interval 
a Adjusted for age, sex, race, education, physical activity, cigarette smoking, and alcohol consumption per week 
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